Alpha-enolase (ENO1) has been reported as a glycolytic enzyme inducing tumorigenesis and tumor invasion under pathological conditions and mediating metabolic reprogramming in cancer cells that performs crucial roles in aerobic glycolysis and acts as a key contributor to the “Warburg effect” in cancer cells [14,15,16,17,18]. Here, ENO1 is linked to cancer.